Deutsche Bank
IMRX icon

Deutsche Bank’s Immuneering IMRX Stock Holding History

Deutsche Bank’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,382
Closed -$32.9K – 3624
2024
Q1 		$32.9K Sell
11,382
-462
-4% -$2.59K ﹤0.01% 3460
2023
Q4 		$87.1K Hold
11,844
– – ﹤0.01% 3281
2023
Q3 		$91K Buy
11,844
+10,793
+1,027% +$99.2K ﹤0.01% 3201
2023
Q2 		$10.7K Buy
+1,051
New +$10.1K ﹤0.01% 3647
2022
Q2 		– Sell
-10,442
Closed -$68K – 4217
2022
Q1 		$68K Buy
10,442
+5,420
+108% +$52.1K ﹤0.01% 3730
2021
Q4 		$81K Buy
5,022
+270
+6% +$6.57K ﹤0.01% 3788
2021
Q3 		$126K Buy
+4,752
New +$128K ﹤0.01% 3801

Other funds holding IMRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deutsche Bank's IMRX Position: Q2 2024 in Review

Deutsche Bank sold out of Immuneering (IMRX) in Q2 2024, closing a stake of 11,382 shares — an estimated $32.9K sold.

Deutsche Bank first reported a position in IMRX in Q3 2021 and held it in 7 quarters. The position peaked at $126K in Q3 2021. 59 funds tracked by Wall St. Rank hold IMRX as of Q2 2024.

  • Deutsche Bank reported no remaining Immuneering position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 11,382 Immuneering shares in Q2 2024, an estimated $32.9K.
  • Deutsche Bank first reported a position in Immuneering in Q3 2021 and held it in 7 quarters.
  • Deutsche Bank's Immuneering position peaked at $126K in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Immuneering as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.